SMLR News and Press, Semler Scientific Inc From 11/02/22

B Riley has downgraded Semler Scientific ( NASDAQ: SMLR ) to neutral from buy due to increased near-term risks associated with Semler's ( SMLR ) variable-fee revenue as a result of CVS' ( CVS ) acquisition of Signify Health, the company's second-largest customer. A...

Semler Scientific ( NASDAQ: SMLR ) stock plunged ~36% on Wednesday after Q3 net income fell and the company reduced its FY22 outlook. Q3 net income declined -11.45% Y/Y to ~$3.68M. GAAP EPS was $0.46 for Q3 2021. Revenue was largely flat Y/Y to $14.05M. ...

Shares of medical diagnostic company Semler Scientific (NASDAQ: SMLR) were plunging today, down 36.4% as of 10:39 a.m. ET. Semler Scientific reported third-quarter earnings last night, showing just flat revenue growth and slightly lower earnings per share than the year-ago quart...

Semler Scientific, Inc. (SMLR) Q3 2022 Earnings Conference Call November 01, 2022, 04:30 PM ET Company Participants Douglas Murphy-Chutorian - CEO, Corporate Secretary Dennis Rosenberg - Chief Marketing Officer Renae Cormier - Head, Corporate Communication and Bu...

Semler Scientific press release ( NASDAQ: SMLR ): Q3 GAAP EPS of $0.55. Revenue of $14M (flat Y/Y). Cash and cash equivalents at September 30, 2022 increased to $45.5 million from $35.9 million Fixed fee software license revenues were $8.6 million, an increase of $...

Semler Reports Third Quarter and Year-to-Date 2022 Financial Results PR Newswire 2022 Q3 quarterly HIGHLIGHTS compared to the corresponding period of 2021: Revenue was $14.0 million , same as the prior year period Net income was $3.7 million , o...

Summary Semler Scientific goes into our spotlight today, as we take our first look at this small cap medical device maker. The stock has lost some 75% of its value over the prior 12 months as growth stocks have been hammered as interest rates have seen a sharp rise in 2022. Is...

Semler to Report Third Quarter and First Nine Months of 2022 Financial Results and Host Conference Call on November 1, 2022 PR Newswire SANTA CLARA, Calif. , Oct. 19, 2022 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides tec...

Summary DPNCheck is a screening product sold to MA insurers which gives better member health outcomes, lower cost, and increased revenue for MA insurers. The product has consistently grown >20%. Discontinuation of Quell marketing in 2018 is masking the strong, underlying growth...

Shares of Semler Scientific (NASDAQ: SMLR) are skyrocketing today, up by 19.1% as of 10:50 a.m. ET. The big gain came after the healthcare technology company announced its second-quarter results following the market close on Tuesday. Semler reported Q2 revenue of $14.8 million, ...